ONCOCRISTIN-AQ
Vincristine
Sun Pharmaceuticals Industries Limite
It available as a solution for injection to be administered by a healthcare provider into the vein.
Stored in refrigerator (2-8 degree C) and protect from light.
Hypersensitivity to the drug Demyelinating form of Charcot-Marie-Tooth syndrome Recent radiation therapy
Peripheral vascular diseases : .
Digoxin: Decreased plasma digoxin levels and renal excretion. L-asparaginase: Hepatic clearance of vincristine is reduced if L-asparaginase is administered first. Thus to minimise toxicity, vincristine should be given 12 to 24 hours before administering L- asparaginase. Mitomycin-C: Acute pulmonary reaction may occur. Phenytoin: Reduced phenytoin plasma levels.
Whether you're looking for a doctor for dealing with your own medical condition, click here to find right physician.
It is any effect of a drug, chemical, or other medicine that is in addition to its intended effect, especially an effect that is harmful or unpleasant.